Menu

Star on GitHub · 3.2k

CVE-2017-9654

8.8 · HIGH

The Philips DoseWise Portal web-based application versions 1.1.7.333 and 2.1.1.3069 stores login credentials in clear text within backend system files.

Published Apr 24, 2018CWE-312EPSS 1.03%

Overview

CVE-2017-9654 is a high-severity vulnerability. It was published on April 24, 2018 and has a CVSS 3.0 base score of 8.8 (HIGH).

This vulnerability has a CVSS 3.0 base score of 8.8, rated HIGH. It can be exploited remotely over the network. Some level of privileges is required for exploitation.

Technical description

The Philips DoseWise Portal web-based application versions 1.1.7.333 and 2.1.1.3069 stores login credentials in clear text within backend system files. CVSS v3 base score: 6.5, CVSS vector string: AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N.

Remediation

Check the references section for vendor advisories, patches, and mitigation guidance. If immediate patching is not possible, review the CVSS vector to understand the attack surface and apply compensating controls such as network segmentation or access restrictions.

Frequently asked questions

What is CVE-2017-9654?

CVE-2017-9654 is a high-severity vulnerability. It was published on April 24, 2018 and has a CVSS 3.0 base score of 8.8 (HIGH).

How severe is CVE-2017-9654?

This vulnerability has a CVSS 3.0 base score of 8.8, rated HIGH. It can be exploited remotely over the network. Some level of privileges is required for exploitation.

How do I fix or remediate CVE-2017-9654?

Check the references section for vendor advisories, patches, and mitigation guidance. If immediate patching is not possible, review the CVSS vector to understand the attack surface and apply compensating controls such as network segmentation or access restrictions.

How can CyberStrike help with CVE-2017-9654?

CyberStrike is an open-source, AI-augmented pentesting engine. Rather than flag a version number, it tests whether an issue like CVE-2017-9654 is actually reachable in your own applications and APIs, then verifies each finding before reporting it. That tells you if the weakness is a real, exploitable risk in your environment or a false positive you can safely deprioritize.

Related HIGH CVEs from 2017

View all